Table 5.
Treatment and clinical outcomes of pneumonia patients with MRSA and non-MRSAa
| Treatment and clinical outcomes |
MRSA |
Non-MRSA |
P-value |
|---|---|---|---|
| (n=78) | (n=865) | ||
| Treatment |
|
|
|
| Intubation in ER |
11 (14.1) |
94 (10.9) |
0.384 |
| Intubation in overall |
18 (23.1) |
185 (21.4) |
0.728 |
| ICU admission via ER |
11 (14.1) |
152 (17.6) |
0.438 |
| ICU admission in overall |
22 (28.2) |
212 (24.5) |
0.469 |
| Clinical outcomes |
|
|
|
| In-hospital mortality |
26 (33.3) |
186 (21.5) |
0.017 |
| Days of ICU stay, median(IQR) |
15.5 (11–30)b |
10 (3–20)c |
0.057 |
| Days of hospital stay, median(IQR) | 16.5 (10–30) | 11 (6–20) | 0.001 |
aData are presented as numbers (percentages) unless otherwise indicated.
bn = 22.
cn = 212.
Abbreviations: MRSA methicillin resistant Staphylococcus aureus, ER emergency room, IQR interquartile range, ICU intensive care unit.